{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:25:46Z","timestamp":1740108346723,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T00:00:00Z","timestamp":1526515200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["the Emerging\/Re-emerging Infectious Disease Project"],"award-info":[{"award-number":["the Emerging\/Re-emerging Infectious Disease Project"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s10096-018-3278-7","type":"journal-article","created":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T22:02:23Z","timestamp":1526508143000},"page":"1511-1519","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["High isolation rate and multidrug resistance tendency of penicillin-susceptible group B Streptococcus with reduced ceftibuten susceptibility in Japan"],"prefix":"10.1007","volume":"37","author":[{"given":"Hirotsugu","family":"Banno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouji","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Seki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanchun","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-ichi","family":"Wachino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshichika","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,17]]},"reference":[{"key":"3278_CR1","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1056\/NEJM199306243282503","volume":"328","author":"MM Farley","year":"1993","unstructured":"Farley MM, Harvey RC, Stull T, Smith JD, Schuchat A, Wenger JD, Stephens DS (1993) A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N Engl J Med 328:1807\u20131811. \n                    https:\/\/doi.org\/10.1056\/NEJM199306243282503","journal-title":"N Engl J Med"},{"key":"3278_CR2","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S0140-6736(03)15389-5","volume":"363","author":"PT Heath","year":"2004","unstructured":"Heath PT, Balfour G, Weisner AM, Efstratiou A, Lamagni TL, Tighe H, O'Connell LA, Cafferkey M, Verlander NQ, Nicoll A, McCartney AC, Group PGBSW (2004) Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet 363:292\u2013294. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(03)15389-5","journal-title":"Lancet"},{"key":"3278_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.7326\/0003-4819-123-6-199509150-00003","volume":"123","author":"LA Jackson","year":"1995","unstructured":"Jackson LA, Hilsdon R, Farley MM, Harrison LH, Reingold AL, Plikaytis BD, Wenger JD, Schuchat A (1995) Risk factors for group B streptococcal disease in adults. Ann Intern Med 123:415\u2013420. \n                    https:\/\/doi.org\/10.7326\/0003-4819-123-6-199509150-00003","journal-title":"Ann Intern Med"},{"key":"3278_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0140-6736(98)07128-1","volume":"353","author":"A Schuchat","year":"1999","unstructured":"Schuchat A (1999) Group B streptococcus. Lancet 353:51\u201356. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(98)07128-1","journal-title":"Lancet"},{"key":"3278_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1086\/599369","volume":"49","author":"TH Skoff","year":"2009","unstructured":"Skoff TH, Farley MM, Petit S, Craig AS, Schaffner W, Gershman K, Harrison LH, Lynfield R, Mohle-Boetani J, Zansky S, Albanese BA, Stefonek K, Zell ER, Jackson D, Thompson T, Schrag SJ (2009) Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin Infect Dis 49:85\u201392. \n                    http:\/\/doi.org\/\n                    \n                  . \n                    https:\/\/doi.org\/10.1086\/599369","journal-title":"Clin Infect Dis"},{"key":"3278_CR6","first-page":"1","volume":"59","author":"JR Verani","year":"2010","unstructured":"Verani JR, McGee L, Schrag SJ, Division of Bacterial Diseases NCfI, Respiratory Diseases CfDC, Prevention (2010) Prevention of perinatal group B streptococcal disease\u2014revised guidelines from CDC, 2010. MMWR Recomm Rep 59:1\u201336","journal-title":"MMWR Recomm Rep"},{"key":"3278_CR7","doi-asserted-by":"crossref","unstructured":"Schuchat A (1998) Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev 11:497\u2013513","DOI":"10.1128\/CMR.11.3.497"},{"key":"3278_CR8","first-page":"1","volume":"51","author":"S Schrag","year":"2002","unstructured":"Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A (2002) Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 51:1\u201322","journal-title":"MMWR Recomm Rep"},{"key":"3278_CR9","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1128\/AAC.00185-08","volume":"52","author":"K Kimura","year":"2008","unstructured":"Kimura K, Suzuki S, Wachino J, Kurokawa H, Yamane K, Shibata N, Nagano N, Kato H, Shibayama K, Arakawa Y (2008) First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother 52:2890\u20132897. \n                    https:\/\/doi.org\/10.1128\/AAC.00185-08","journal-title":"Antimicrob Agents Chemother"},{"key":"3278_CR10","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1128\/AAC.01716-08","volume":"53","author":"SY Murayama","year":"2009","unstructured":"Murayama SY, Seki C, Sakata H, Sunaoshi K, Nakayama E, Iwata S, Sunakawa K, Ubukata K, Invasive Streptococcal Disease Working G (2009) Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections. Antimicrob Agents Chemother 53:2650\u20132653. \n                    https:\/\/doi.org\/10.1128\/AAC.01716-08","journal-title":"Antimicrob Agents Chemother"},{"key":"3278_CR11","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.1128\/AAC.00596-08","volume":"52","author":"N Nagano","year":"2008","unstructured":"Nagano N, Nagano Y, Kimura K, Tamai K, Yanagisawa H, Arakawa Y (2008) Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother 52:4258\u20134267. \n                    https:\/\/doi.org\/10.1128\/AAC.00596-08","journal-title":"Antimicrob Agents Chemother"},{"key":"3278_CR12","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1093\/jac\/dkp458","volume":"65","author":"C Gaudreau","year":"2010","unstructured":"Gaudreau C, Lecours R, Ismail J, Gagnon S, Jette L, Roger M (2010) Prosthetic hip joint infection with a Streptococcus agalactiae isolate not susceptible to penicillin G and ceftriaxone. J Antimicrob Chemother 65:594\u2013595. \n                    https:\/\/doi.org\/10.1093\/jac\/dkp458","journal-title":"J Antimicrob Chemother"},{"key":"3278_CR13","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1128\/AAC.01243-10","volume":"55","author":"J Longtin","year":"2011","unstructured":"Longtin J, Vermeiren C, Shahinas D, Tamber GS, McGeer A, Low DE, Katz K, Pillai DR (2011) Novel mutations in a patient isolate of Streptococcus agalactiae with reduced penicillin susceptibility emerging after long-term oral suppressive therapy. Antimicrob Agents Chemother 55:2983\u20132985. \n                    https:\/\/doi.org\/10.1128\/AAC.01243-10","journal-title":"Antimicrob Agents Chemother"},{"key":"3278_CR14","doi-asserted-by":"publisher","unstructured":"Dahesh S, Hensler ME, Van Sorge NM, Gertz RE, Jr., Schrag S, Nizet V, Beall BW. (2008) Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics. Antimicrob Agents Chemother 52:2915\u20132918. \n                    https:\/\/doi.org\/10.1128\/AAC.00461-08","DOI":"10.1128\/AAC.00461-08"},{"key":"3278_CR15","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/jac\/dks423","volume":"68","author":"K Kimura","year":"2013","unstructured":"Kimura K, Nagano N, Nagano Y, Suzuki S, Wachino J, Shibayama K, Arakawa Y (2013) High frequency of fluoroquinolone- and macrolide-resistant streptococci among clinically isolated group B streptococci with reduced penicillin susceptibility. J Antimicrob Chemother 68:539\u2013542. \n                    https:\/\/doi.org\/10.1093\/jac\/dks423","journal-title":"J Antimicrob Chemother"},{"key":"3278_CR16","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/jac\/dkr546","volume":"67","author":"N Nagano","year":"2012","unstructured":"Nagano N, Nagano Y, Toyama M, Kimura K, Tamura T, Shibayama K, Arakawa Y (2012) Nosocomial spread of multidrug-resistant group B streptococci with reduced penicillin susceptibility belonging to clonal complex 1. J Antimicrob Chemother 67:849\u2013856. \n                    https:\/\/doi.org\/10.1093\/jac\/dkr546","journal-title":"J Antimicrob Chemother"},{"key":"3278_CR17","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1128\/JCM.01291-14","volume":"52","author":"N Nagano","year":"2014","unstructured":"Nagano N, Nagano Y, Toyama M, Kimura K, Shibayama K, Arakawa Y (2014) Penicillin-susceptible group B streptococcal clinical isolates with reduced cephalosporin susceptibility. J Clin Microbiol 52:3406\u20133410. \n                    https:\/\/doi.org\/10.1128\/JCM.01291-14","journal-title":"J Clin Microbiol"},{"key":"3278_CR18","first-page":"M100","volume-title":"Performance standards for antimicrobial susceptibility testing, 20th ed","author":"Clinical and Laboratory Standards Institute","year":"2010","unstructured":"Clinical and Laboratory Standards Institute (2010) Performance standards for antimicrobial susceptibility testing, 20th ed. Clinical and Laboratory Standards Institute, Wayne, PA, p M100"},{"key":"3278_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183453","volume":"12","author":"H Banno","year":"2017","unstructured":"Banno H, Kimura K, Tanaka Y, Sekizuka T, Kuroda M, Jin W, Wachino JI, Yamada K, Shibayama K, Arakawa Y (2017) Analysis of multidrug resistant group B streptococci with reduced penicillin susceptibility forming small, less hemolytic colonies. PLoS One 12:e0183453. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0183453","journal-title":"PLoS One"},{"key":"3278_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1128\/JCM.42.1.83-89.2004","volume":"42","author":"SM Hansen","year":"2004","unstructured":"Hansen SM, Uldbjerg N, Kilian M, Sorensen UB (2004) Dynamics of Streptococcus agalactiae colonization in women during and after pregnancy and in their infants. J Clin Microbiol 42:83\u201389. \n                    https:\/\/doi.org\/10.1128\/JCM.42.1.83-89.2004","journal-title":"J Clin Microbiol"},{"key":"3278_CR21","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1093\/jac\/dkv203","volume":"70","author":"T Seki","year":"2015","unstructured":"Seki T, Kimura K, Reid ME, Miyazaki A, Banno H, Jin W, Wachino J, Yamada K, Arakawa Y (2015) High isolation rate of MDR group B streptococci with reduced penicillin susceptibility in Japan. J Antimicrob Chemother 70:2725\u20132728. \n                    https:\/\/doi.org\/10.1093\/jac\/dkv203","journal-title":"J Antimicrob Chemother"},{"key":"3278_CR22","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1128\/JCM.01183-16","volume":"54","author":"M Morozumi","year":"2016","unstructured":"Morozumi M, Wajima T, Takata M, Iwata S, Ubukata K (2016) Molecular characteristics of group B streptococci isolated from adults with invasive infections in Japan. J Clin Microbiol 54:2695\u20132700. \n                    https:\/\/doi.org\/10.1128\/JCM.01183-16","journal-title":"J Clin Microbiol"},{"key":"3278_CR23","doi-asserted-by":"publisher","first-page":"574 e577","DOI":"10.1016\/j.cmi.2017.02.021","volume":"23","author":"BJ Metcalf","year":"2017","unstructured":"Metcalf BJ, Chochua S, Gertz RE Jr, Hawkins PA, Ricaldi J, Li Z, Walker H, Tran T, Rivers J, Mathis S, Jackson D, Glennen A, Lynfield R, McGee L, Beall B, Active Bacterial Core surveillance t (2017) Short-read whole genome sequencing for determination of antimicrobial resistance mechanisms and capsular serotypes of current invasive Streptococcus agalactiae recovered in the USA. Clin Microbiol Infect 23:574 e577\u2013574 e514. \n                    https:\/\/doi.org\/10.1016\/j.cmi.2017.02.021","journal-title":"Clin Microbiol Infect"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-018-3278-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3278-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3278-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T19:15:09Z","timestamp":1558034109000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-018-3278-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,17]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["3278"],"URL":"https:\/\/doi.org\/10.1007\/s10096-018-3278-7","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"type":"print","value":"0934-9723"},{"type":"electronic","value":"1435-4373"}],"subject":[],"published":{"date-parts":[[2018,5,17]]},"assertion":[{"value":"21 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.As this study pertains to the characterization of bacterial isolates only, and as we did not obtain or use clinical or personal information, this type of study does not require examination or approval of an ethical committee according to the related guidelines of the Japanese government.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent is not applicable, as this article does not contain any studies with human participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}